Surgery provides more dramatic, longer-lasting results
Six tools, six logins, six invoices, zero integration
Early trials suggest it may be effective not just on its own, but especially when combined with GLP-1 therapies, creating a powerful one-two punch against overeating and excess weight
retatrutide reached 28.3% in TRIUMPH-1 at 80 weeks, with extension data reaching 30.3% at 104 weeks
Use a non-oral or backup method of contraception for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase
Stewart, MD, FRCP, FMedSci, executive dean and professor at the University of Leeds School of Medicine in the United Kingdom, selected three papers from JCEM, which as he pointed out, was not an easy task given that JCEM publishes more than 500 articles a year